Cubist Pharmaceuticals Inc

8-K

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

01/21/15

8-K

Announces Withdrawal of Listing of CVRs (CBSTZ) From NASDAQ Global Select Market

01/13/15

8-K

Notice of Failure Purchase to the Holders of The

01/02/15

8-K

ZERBAXA Addresses Certain Serious and Resistant Gram-Negative Bacteria First New Antibiotic Approved in U.S. Under the GAIN Act That Treats Gram-Negative Bacteria

12/22/14

8-K

Reason for the Tender Offer Blackout Period and This Notice

12/19/14

8-K

######## ## ####### ###### ##########

12/09/14

8-K

##### ## ####### ###### ############### ### #### ### ##### ## #### ########### ######## ####### ###### ########## ### ########### ### ###### ## ######## ##### #### ######

12/08/14

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Cubist Pharmaceuticals Inc Watch